Tag: Phase II Trial
Aquestive Receives Positive FDA Response to Epinephrine Sublingual Film Phase 2...
Response confirms approach and supports the characterization of their novel drug platform.
Aquestive’s Sublingual Emergency Epinephrine Compares Favorably to EpiPen® in EPIPHAST II...
The company announced topline results from their EPIPHAST II study.
Siolta Begins Phase 2 Study in Newborns of Bacteria Consortia ...
STMC-103H has a combination of bacteria that are depleted in the gut microbiota of infants who go on to develop allergic sensitization and allergic diseases in childhood.
Aquestive Reports Positive Results from Sublingual Epinephrine Clinical Trial
Phase 2 study continues to show AQST-109 is safe and well tolerated.
Positive Early Results with Fecal Microbiota Therapy for Peanut-Allergic Patients
Encapsulated stool from non-allergic donors alters the immune system and increases tolerance to peanuts.
Revolo Biotherapeutics Announces Open Enrollment for Phase 2 Clinical Trial of...
Revolo Biotherapeutics announced it has activated clinical sites and opened enrollment in a Phase 2 clinical trial of its eosinophilic esophagitis therapy.
COUR Announces First In-Human Dosing in Proof-of-Concept Trial of CNP-201 to...
CNP-201 is a nanoparticle containing peanut protein that aims to eliminate allergic responses.
Alladapt Enrolling Participants for Clinical Study of OIT Therapy to Treat...
The study is still seeking participants 4-55 years of age.
Michigan Medicine Helps Lead First National Study on How Highly Allergic...
First volunteer expected to receive an injection April 7 in Ann Arbor with results anticipated this summer.
Study: Few People with Peanut Allergy Tolerate Peanut after Stopping OIT
Continuing with a modest dose confers more protection, NIH-funded study finds.
